I am a scientist, technologist, and entrepreneur with over 15 years of experience in artificial intelligence, health, data science, and cryptocurrencies. I am currently the Chief Innovation Officer at Sama Therapeutics, where I lead innovation and development of the iMAGiNE precision ...more

I am a scientist, technologist, and entrepreneur with over 15 years of experience in artificial intelligence, health, data science, and cryptocurrencies. I am currently the Chief Innovation Officer at Sama Therapeutics, where I lead innovation and development of the iMAGiNE precision neuropsychiatry AI/ML platform. This platform enables transdiagnostic biomarker discovery for drug and device development, fundamental neuroscience research, and patient clinical decision support. I have co-founded and served as the Chief Scientific Officer of several companies in the AI and biotech domains, with successful exits and acquisitions. I have also conducted scientific and technical due diligence on $100M+ transactions in AI drug discovery. With our teams and collaborators we have published scientific papers in peer-reviewed journals on AI and neurodegenerative disease, neuropathology, immunology, biosensors, and radiology. As a keynote speaker and conference moderator, I have spoken at conferences worldwide on biotechnology, AI, cryptocurrencies, and neurotechnology for diverse audiences. My mission is to leverage AI, chemistry, synthetic biology, and data science to advance human health and wellbeing around the world. In crypto and DeFi I was an early employee at Consensys in Brooklyn, NY and serve as AI & Data Science Advisor for SuperDuper: Portal Fever: Record $8.6 Billion Staked for Binance Rewards Ahead of Game Token Airdrop https://decrypt.co/218764/portal-record-binance-launchpool-gaming-token-airdrop Pre-acquisition/pre-IPO scientific and technical due diligence: Beauty company Oddity to acquire AI biotech startup Revela for $76 million https://www.voguebusiness.com/beauty/beauty-oddity-acquire-ai-biotech-startup-revela-76-million-il-makiage Il Makiage parent Oddity buys biotech startup Revela to design new molecules for beauty products https://www.cnbc.com/2023/04/27/oddity-acquires-biotech-startup-revela-in-76-million-deal.html Please use email rather than LinkedIn messaging: Email russellhanson at gmail dot com.less